BioNexus Gene Lab Corp - 8-K Filing

BioNexus Gene Lab Corp participated in the 2026 China-Malaysia Economic Cooperation Outlook Forum on May 21, 2026 and called for deeper biotechnology collaboration between Malaysia and China beyond traditional trade. CEO Sam Tan emphasized building a precision healthcare corridor focused on co-development, clinical validation, commercialization, and regional access. The company highlighted its VitaGuard™ MRD platform and Fidelion Diagnostics model as examples of cross-border innovation structures. (Items: 8.01 Other Events On May 29, 2026, BioNexus Gene Lab Corp, 9.01 Financial Statement and Exhibits)

SEC EDGAR · June 5, 2026, 13:01 UTC

Tickers: $BGLC

Read the full article at SEC EDGAR

More Regulatory news

REGIONAL HEALTH PROPERTIES, INC - 8-K Filing SEC EDGAR · November 12, 2026, 15:09 UTC
Bitwise Avalanche ETF - 8-K Filing SEC EDGAR · November 12, 2026, 15:06 UTC
MiNK Therapeutics, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 15:05 UTC
Future Vision II Acquisition Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 15:00 UTC
THUNDER MOUNTAIN GOLD INC - 10-Q Filing SEC EDGAR · November 12, 2026, 15:00 UTC
MiNK Therapeutics, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:49 UTC
SusGlobal Energy Corp. - 10-Q Filing SEC EDGAR · November 12, 2026, 14:42 UTC
Ideal Power Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 14:25 UTC
DIGI INTERNATIONAL INC - 8-K Filing SEC EDGAR · November 12, 2026, 14:23 UTC
ZeroStack Corp. - 8-K Filing SEC EDGAR · November 12, 2026, 14:22 UTC